Scholarlink

Background <p>Ischemic leg ulcers (ILU) represent a severe manifestation of chronic limb-threatening ischemia (CLTI), characterized by high recurrence and amputation rates. This study evaluated the efficacy and safety of tibial periosteal distraction (TPD) for treating ILU through a combination of animal experiments and clinical trials.</p> Methods <p>Nine Beagle dogs were randomly allocated into TPD group, tibial soft tissue distraction (TSD) group, and control group. Standardized 15-mm circular wounds were created on the foot, followed by periosteal distraction at a rate of 0.5&#xa0;mm/day for 11&#xa0;days. Parameters assessed included wound healing rates, serum VEGF levels, histopathological changes, and CT angiography/perfusion parameters. A multicenter retrospective cohort study was conducted from June 2019 to January 2024, enrolling 103 ILU patients treated with TPD compared with 127 patients receiving conventional treatment. Primary endpoints included ulcer healing rates at 3 and 6&#xa0;months, amputation rates, and recurrence within 1&#xa0;year. Secondary endpoints comprised complications and safety assessments.</p> Results <p>In animal study, the TPD group demonstrated accelerated wound healing compared to both control and TSD groups, with residual wound area of 2.08 ± 1.68% on day 16, versus 5.46 ± 1.98% in the control group and 12.49 ± 2.97% in the TSD group. Serum VEGF levels were markedly elevated in the TPD group from days 8 to 16 (peak: 27.25 ± 2.16&#xa0;pg/ml vs. 17.90 ± 1.72&#xa0;pg/ml in controls, <i>P</i> &lt; 0.01). CT angiography revealed enhanced collateral circulation in the distraction region with increased tissue perfusion parameters (equivalent blood volume&#xa0;and arterial flow). In clinical study, the TPD group achieved superior healing rates compared to controls: 90.3% vs. 77.2% at 3&#xa0;months (<i>P</i> = 0.008) and 94.2% vs. 85.8% at 6&#xa0;months (<i>P</i> = 0.039). Major amputation rate was reduced in the TPD group (2.9% vs. 9.5%, <i>P</i> = 0.046), while minor amputation rates showed no significant difference (38.8% vs. 44.1%, <i>P</i> = 0.421). Recurrence within 1&#xa0;year was markedly decreased (8.7% vs. 19.7%, <i>P</i> = 0.020). Complications included pin tract infection in 7 cases (6.8%) and pain intolerance requiring distraction rate adjustment in 9 cases (8.7%), all successfully managed with conservative treatment.</p> Conclusions <p>TPD offers a promising therapeutic option for CLTI patients, particularly those unsuitable for vascular reconstruction. Further prospective randomized trials are warranted to establish standardized protocols and optimize treatment parameters.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Tibial periosteal distraction for ischemic leg ulcers: animal and clinical cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月28日

查看全文
  • Peilin Zhou,
  • Wenqiang Wang,
  • Yi You,
  • Nian Zhou,
  • Taifeng Zhang,
  • Jiangtao Yang,
  • Xiang Chen,
  • Linghui Tang,
  • Meng Gan,
  • Wei Xu,
  • Wengao Wu,
  • Boyang Liu,
  • Huiyan Liu,
  • Xiaochong Zou,
  • Yongzhen Liu,
  • Xiao Peng,
  • Lu Wei,
  • Xingyu Chen,
  • Feng Yang,
  • Yueyue Zhu,
  • Ruibin Feng,
  • Xiaoping Yu,
  • Junliang Ye,
  • Ronghan Wu,
  • Yu Chen,
  • Lan Lan,
  • Jiajun Chen,
  • Yi Ding,
  • Xinyu Nie,
  • Bingfeng Lu,
  • Naxin Zeng,
  • Qikai Hua

摘要

Background

Ischemic leg ulcers (ILU) represent a severe manifestation of chronic limb-threatening ischemia (CLTI), characterized by high recurrence and amputation rates. This study evaluated the efficacy and safety of tibial periosteal distraction (TPD) for treating ILU through a combination of animal experiments and clinical trials.

Methods

Nine Beagle dogs were randomly allocated into TPD group, tibial soft tissue distraction (TSD) group, and control group. Standardized 15-mm circular wounds were created on the foot, followed by periosteal distraction at a rate of 0.5 mm/day for 11 days. Parameters assessed included wound healing rates, serum VEGF levels, histopathological changes, and CT angiography/perfusion parameters. A multicenter retrospective cohort study was conducted from June 2019 to January 2024, enrolling 103 ILU patients treated with TPD compared with 127 patients receiving conventional treatment. Primary endpoints included ulcer healing rates at 3 and 6 months, amputation rates, and recurrence within 1 year. Secondary endpoints comprised complications and safety assessments.

Results

In animal study, the TPD group demonstrated accelerated wound healing compared to both control and TSD groups, with residual wound area of 2.08 ± 1.68% on day 16, versus 5.46 ± 1.98% in the control group and 12.49 ± 2.97% in the TSD group. Serum VEGF levels were markedly elevated in the TPD group from days 8 to 16 (peak: 27.25 ± 2.16 pg/ml vs. 17.90 ± 1.72 pg/ml in controls, P < 0.01). CT angiography revealed enhanced collateral circulation in the distraction region with increased tissue perfusion parameters (equivalent blood volume and arterial flow). In clinical study, the TPD group achieved superior healing rates compared to controls: 90.3% vs. 77.2% at 3 months (P = 0.008) and 94.2% vs. 85.8% at 6 months (P = 0.039). Major amputation rate was reduced in the TPD group (2.9% vs. 9.5%, P = 0.046), while minor amputation rates showed no significant difference (38.8% vs. 44.1%, P = 0.421). Recurrence within 1 year was markedly decreased (8.7% vs. 19.7%, P = 0.020). Complications included pin tract infection in 7 cases (6.8%) and pain intolerance requiring distraction rate adjustment in 9 cases (8.7%), all successfully managed with conservative treatment.

Conclusions

TPD offers a promising therapeutic option for CLTI patients, particularly those unsuitable for vascular reconstruction. Further prospective randomized trials are warranted to establish standardized protocols and optimize treatment parameters.

Graphical Abstract